[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352115-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352115-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","saudi-patient-derived-brain-and-intracranial-explanted-tumor-cells-isolation-growth-and-anticancer-drug-screening","Saudi Patient-Derived Brain and Intracranial Explanted Tumor Cells - Isolation, Growth, and Anticancer Drug Screening","","Brain cancer is a highly aggressive disease with limited treatment options, highlighting the need for reliable preclinical models for drug discovery. This study isolated and characterized Saudi patient-derived primary brain cancer cells and evaluated the anticancer activity of novel in-house compounds. Sixteen tumor samples were processed to establish primary cultures, and normal tissue served as control. Cells were maintained under optimized conditions, morphology and growth were tracked, marker expression was confirmed, and cytotoxicity was measured using MTT and CellTiter-Glo assays, showing concentration-dependent viability reduction with strongest effects at 25 µM, reflecting patient-tumor heterogeneity.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/saudi-patient-derived-brain-and-intracranial-explanted-tumor-cells-isolation-growth-and-anticancer-drug-screening/352115/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/saudi-patient-derived-brain-and-intracranial-explanted-tumor-cells-isolation-growth-and-anticancer-drug-screening/352115.png","ImageObject",300,407,{"name":42,"@type":43},"mieayamfan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-17","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main goal of this study?","Question",{"text":63,"@type":64},"To isolate and characterize Saudi patient-derived primary brain cancer cells and assess anticancer activity of selected in-house compounds.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the tumor cell models established?",{"text":68,"@type":64},"Sixteen tumor samples from Saudi patients were processed to establish primary brain cancer cultures, with one normal tissue sample used as control.",{"name":70,"@type":61,"acceptedAnswer":71},"Which assays were used to evaluate anticancer effects?",{"text":72,"@type":64},"The anticancer activity of compounds KCO69, KCO70, and KCO129 was tested using MTT and CellTiter-Glo Luminescent Cell Viability assays.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352115,1790616576,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090893677,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Article  \nSaudi Patient-Derived Brain and Intracranial Explanted Tumor Cells: Isolation, Growth, and Anticancer Drug Screening  \nSaba M. Alsubaie 1,2, Rafa Almeer 2, Ali H. Alassiri 1,3, Ahmed Alkhani 4, Fahd AlSufiani 3, Imadul Islam 1, Mohamed Boudjelal 1 and Rizwan Ali 1, *  \nAcademic Editor: Odília Queirós  \nReceived: 23 April 2026  \nRevised: 24 May 2026  \nAccepted: 25 May 2026  \nPublished: 9 August 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 King Abdullah International Medical Research Center (KAIMRC), King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh 14811, Saudi Arabia; [ranyasms@windowslive.com](ranyasms@windowslive.com) (S.M.A.)  \n2 Zoology Department, King Saud University, Riyadh 11451, Saudi Arabia  \n3 Department of Pathology and Laboratory Medicine, King Abdulaziz Medical City, Ministry of National Guard—Health Affairs, Riyadh 11426, Saudi Arabia  \n4 Division of Neurosurgery, Department of Surgery, King Abdulaziz Medical City, Ministry of National Guard—Health Affairs, Riyadh 11426, Saudi Arabia  \n* Correspondence: [aliri@kaimrc.med.sa](aliri@kaimrc.med.sa)  \nAbstract  \nBrain cancer is a highly aggressive disease with limited treatment options, highlighting the need for reliable preclinical models for drug discovery. This study aimed to isolate and characterize Saudi patient-derived primary brain cancer cells and assess the anticancer activity of novel compounds developed in-house. Sixteen tumor samples from Saudi patients were processed to establish primary brain cancer cultures and One Normal Tissue (Control) . The cells were successfully isolated and maintained under optimized conditions, with their morphology and growth characteristics monitored. Molecular analysis confirmed the expression of key tumor and neural markers. The anticancer activity of selected compounds, KCO69, KCO70, and KCO129, was tested at various concentrations using the MTT and CellTiter-Glo Luminescent Cell Viability Assay. All compounds caused a concentration-dependent reduction in cell viability, with the strongest effects seen at 25 µM. Among them, compound 70 showed the most significant antiproliferative activity, while compounds KCO69 and KCO129 exhibited moderate effects. Variability in treatment response among cultures reflected the inherent heterogeneity of patient-derived tumors. Overall, establishing primary brain cancer cell models from Saudi patients offers a valuable platform for preclinical drug screening and supports further research on these compounds as potential therapies for brain cancer.  \nKeywords: brain tumor; drug treatment; microscopy; quinoline-based compounds  \n1. Introduction  \nCancer has become one of the most significant global health challenges, with its incidence increasing from the 20th to the 21st century. Current data show that about one in four people is at risk of developing cancer during their lifetime, highlighting the urgent need for ongoing research and effective prevention strategies, especially scientific research based on primary human cancer cells [1] .  \nBrain cancer encompasses malignant conditions affecting the brain, cranial nerves, spinal nerves, spinal cord, and meninges. These cancers are inherently primitive, invasive, and aggressive, often resulting in low survival rates following diagnosis. Brain tumors  \nare categorized by their nature, origin, growth velocity, and stage of progression, and can be classified as benign or malignant [2] . The World Health Organization (WHO) assigns these tumors into four grades (I–IV) based on their aggressiveness. Common examples include metastatic brain tumors, meningiomas, astrocytoma, and glioblastomas. Notably, glioblastoma is among the most aggressive primary brain tumors, characterized by its infiltration into surrounding bra","cbCaic6JOVFaACBt","https://ap.wps.com/l/cbCaic6JOVFaACBt","pdf",6943934,22,"English","# Abstract\n# Introduction","[{\"question\":\"What was the main goal of this study?\",\"answer\":\"To isolate and characterize Saudi patient-derived primary brain cancer cells and assess anticancer activity of selected in-house compounds.\"},{\"question\":\"How were the tumor cell models established?\",\"answer\":\"Sixteen tumor samples from Saudi patients were processed to establish primary brain cancer cultures, with one normal tissue sample used as control.\"},{\"question\":\"Which assays were used to evaluate anticancer effects?\",\"answer\":\"The anticancer activity of compounds KCO69, KCO70, and KCO129 was tested using MTT and CellTiter-Glo Luminescent Cell Viability assays.\"}]","Saudi Patient-Derived Brain and Intracranial Explanted Tumor Cells - Isolation, Growth, and Anticancer Drug Screening | PDF",1790097766,55,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cc7e2b624f45a030add9569a2e7610a2.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/27b359d2cb9cb66d854427e260678f4c.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/707f7c4341edde6e0be1b2d0056126a8.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/074d51ae5aa90ddda8148d2c003857cc.webp",980,1385]